Get started
Live feed
PRReleasevia Quantisnow
Enlivex Ltd. logo

Allocetra Shows Durable 6-Month Efficacy in Knee Osteoarthritis Phase IIa Trial; Oral Presentation at EULAR 2026

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for ENLV

Across the 20 sessions after earlier ENLV headlines, the stock closed higher 12 times and lower 6 times, with a median move of 4.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

ENLV close-to-close change in the session after earlier headlines
SessionEarlier headlineENLVSPY
May 28, 2026Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.16 Billion; Rain Foundation Appoints Industry Leaders to Advisory Board-2.2%+0.6%
May 27, 2026Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity+14.3%-0.0%
May 18, 2026Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritisand 1 other headline that session-3.2%-0.1%
Apr 30, 2026Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange+2.3%+1.0%
Apr 28, 2026Enlivex Treasury Update: Total RAIN Holdings Rise to 78,819,756,062 Tokens as of April 27, 2026, Representing an Aggregated Value of $567 Million-6.4%-0.5%
Apr 23, 2026Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress+2.0%-0.4%
Quantisnow market dataNASDAQ
Enlivex Ltd. logo
ENLV
Enlivex Ltd.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2014
Get push alerts for ENLV

Follow ENLV and get a push notification the moment its next story breaks.

Full ENLV profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ENLV (Enlivex Ltd.) and more on Quantisnow.